Markedly increased ocular side effect causing severe vision deterioration after chemotherapy using new or investigational epidermal or fibroblast growth factor receptor inhibitors
- DOI
- 10.1186/s12886-019-1285-9
- Published
- 2020-01-09
- Container
- BMC Ophthalmology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12886-019-1285-9,
title = {Markedly increased ocular side effect causing severe vision deterioration after chemotherapy using new or investigational epidermal or fibroblast growth factor receptor inhibitors},
author = {Eunhae Shin and Dong Hui Lim and Jisang Han and Do-Hyun Nam and Keunchil Park and Myung-Ju Ahn and Won Ki Kang and Jeeyun Lee and Jin Seok Ahn and Se-Hoon Lee and Jong-Mu Sun and Hyun Ae Jung and Tae-Young Chung},
year = {2020},
journal = {BMC Ophthalmology},
doi = {10.1186/s12886-019-1285-9},
url = {https://doi.org/10.1186/s12886-019-1285-9}
}RIS
TY - JOUR TI - Markedly increased ocular side effect causing severe vision deterioration after chemotherapy using new or investigational epidermal or fibroblast growth factor receptor inhibitors AU - Eunhae Shin AU - Dong Hui Lim AU - Jisang Han AU - Do-Hyun Nam AU - Keunchil Park AU - Myung-Ju Ahn AU - Won Ki Kang AU - Jeeyun Lee AU - Jin Seok Ahn AU - Se-Hoon Lee AU - Jong-Mu Sun AU - Hyun Ae Jung AU - Tae-Young Chung PY - 2020 JO - BMC Ophthalmology DO - 10.1186/s12886-019-1285-9 UR - https://doi.org/10.1186/s12886-019-1285-9 ER -
APA
Shin, E., Lim, D. H., Han, J., Nam, D., Park, K., Ahn, M., Kang, W. K., Lee, J., Ahn, J. S., Lee, S., Sun, J., Jung, H. A., & Chung, T. (2020). Markedly increased ocular side effect causing severe vision deterioration after chemotherapy using new or investigational epidermal or fibroblast growth factor receptor inhibitors. BMC Ophthalmology. https://doi.org/10.1186/s12886-019-1285-9
Source records
- crossref · retrieved 2026-09-26T04:54:11.224Z